Walleye Capital LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 187 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,114,331
-43.9%
257,947
-14.4%
0.00%
-57.1%
Q2 2023$1,985,112
-7.3%
301,231
-4.5%
0.01%
-78.1%
Q1 2023$2,141,356
+97.1%
315,369
+114.5%
0.03%
+60.0%
Q4 2022$1,086,626
-48.6%
147,040
-24.3%
0.02%
-65.5%
Q2 2022$2,116,000
+192.3%
194,164
+203.1%
0.06%
+205.3%
Q1 2022$724,000
-57.5%
64,050
-41.0%
0.02%
-64.2%
Q4 2021$1,702,000108,4910.05%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders